HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Sentry Investment Management LLC

Sentry Investment Management LLC decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 17.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 867 shares of the company’s stock after selling 178 shares during the period. Sentry Investment Management LLC’s holdings in HCA Healthcare were worth $279,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. HHM Wealth Advisors LLC boosted its holdings in HCA Healthcare by 0.9% in the second quarter. HHM Wealth Advisors LLC now owns 4,548 shares of the company’s stock valued at $1,461,000 after purchasing an additional 40 shares during the last quarter. Angeles Wealth Management LLC grew its position in shares of HCA Healthcare by 37.0% during the second quarter. Angeles Wealth Management LLC now owns 836 shares of the company’s stock worth $269,000 after buying an additional 226 shares in the last quarter. AMJ Financial Wealth Management raised its holdings in HCA Healthcare by 27.8% in the second quarter. AMJ Financial Wealth Management now owns 25,573 shares of the company’s stock valued at $8,216,000 after acquiring an additional 5,556 shares in the last quarter. Coldstream Capital Management Inc. increased its position in shares of HCA Healthcare by 3.6% in the 2nd quarter. Coldstream Capital Management Inc. now owns 3,074 shares of the company’s stock worth $988,000 after purchasing an additional 108 shares during the last quarter. Finally, Daiwa Securities Group Inc. lifted its position in shares of HCA Healthcare by 11.1% during the second quarter. Daiwa Securities Group Inc. now owns 37,779 shares of the company’s stock worth $12,138,000 after purchasing an additional 3,781 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have commented on HCA. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Morgan Stanley started coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective for the company. Truist Financial raised their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Barclays raised their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Finally, Oppenheimer increased their price target on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Stock Up 0.6 %

Shares of HCA stock opened at $388.65 on Thursday. The business’s fifty day moving average is $359.40 and its 200-day moving average is $337.17. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $403.05. The stock has a market cap of $101.79 billion, a PE ratio of 19.37, a price-to-earnings-growth ratio of 1.45 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.29 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 22.48 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Insider Activity at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,844 shares of company stock worth $3,185,932. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.